ABBVIE INC (ABBV) Fundamental Analysis & Valuation
NYSE:ABBV • US00287Y1091
Current stock price
203.89 USD
+6.2 (+3.14%)
At close:
203.71 USD
-0.18 (-0.09%)
Pre-Market:
This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABBV Profitability Analysis
1.1 Basic Checks
- In the past year ABBV was profitable.
- ABBV had a positive operating cash flow in the past year.
- In the past 5 years ABBV has always been profitable.
- In the past 5 years ABBV always reported a positive cash flow from operatings.
1.2 Ratios
- ABBV has a better Return On Assets (3.12%) than 89.51% of its industry peers.
- ABBV's Return On Invested Capital of 14.42% is amongst the best of the industry. ABBV outperforms 95.73% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ABBV is significantly below the industry average of 28.06%.
- The 3 year average ROIC (12.12%) for ABBV is below the current ROIC(14.42%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- With an excellent Profit Margin value of 6.84%, ABBV belongs to the best of the industry, outperforming 89.90% of the companies in the same industry.
- ABBV's Profit Margin has declined in the last couple of years.
- The Operating Margin of ABBV (34.23%) is better than 96.50% of its industry peers.
- ABBV's Operating Margin has improved in the last couple of years.
- ABBV's Gross Margin of 71.62% is amongst the best of the industry. ABBV outperforms 80.19% of its industry peers.
- ABBV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. ABBV Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABBV is creating some value.
- ABBV has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for ABBV remains at a similar level compared to 5 years ago.
- The debt/assets ratio for ABBV is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.26 indicates that ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.26, ABBV is in the better half of the industry, outperforming 66.60% of the companies in the same industry.
- ABBV has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as ABBV would need 3.79 years to pay back of all of its debts.
- ABBV has a better Debt to FCF ratio (3.79) than 92.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.26 |
ROIC/WACC1.61
WACC8.98%
2.3 Liquidity
- ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- ABBV's Current ratio of 0.67 is on the low side compared to the rest of the industry. ABBV is outperformed by 90.87% of its industry peers.
- ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- ABBV has a worse Quick ratio (0.56) than 91.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. ABBV Growth Analysis
3.1 Past
- ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.78%.
- The Earnings Per Share has been decreasing by -0.99% on average over the past years.
- ABBV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
- ABBV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.95% yearly.
EPS 1Y (TTM)-0.78%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%7.72%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%12.43%
3.2 Future
- The Earnings Per Share is expected to grow by 14.94% on average over the next years. This is quite good.
- Based on estimates for the next years, ABBV will show a small growth in Revenue. The Revenue will grow by 6.37% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y14.94%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.37%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. ABBV Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 20.01 indicates a rather expensive valuation of ABBV.
- 93.20% of the companies in the same industry are more expensive than ABBV, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of ABBV to the average of the S&P500 Index (26.54), we can say ABBV is valued slightly cheaper.
- ABBV is valuated correctly with a Price/Forward Earnings ratio of 12.42.
- ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABBV is cheaper than 97.48% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ABBV to the average of the S&P500 Index (21.68), we can say ABBV is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.01 | ||
| Fwd PE | 12.42 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ABBV is valued cheaper than 94.17% of the companies in the same industry.
- ABBV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABBV is cheaper than 95.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.24 | ||
| EV/EBITDA | 14.46 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of ABBV may justify a higher PE ratio.
- A more expensive valuation may be justified as ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%
5. ABBV Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.39%, ABBV has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.68, ABBV pays a better dividend. On top of this ABBV pays more dividend than 99.42% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, ABBV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
5.2 History
- The dividend of ABBV is nicely growing with an annual growth rate of 6.76%!
- ABBV has paid a dividend for at least 10 years, which is a reliable track record.
- ABBV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.76%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
- ABBV pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
- ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
ABBV Fundamentals: All Metrics, Ratios and Statistics
203.89
+6.2 (+3.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength54.66
Industry Growth13.04
Earnings (Last)04-29 2026-04-29/bmo
Earnings (Next)N/A N/A
Inst Owners76.21%
Inst Owner Change-0.09%
Ins Owners0.05%
Ins Owner Change6.1%
Market Cap360.63B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target256.53 (25.82%)
Short Float %1.24%
Short Ratio3.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.39% |
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years12
Div Non Decr Years12
Ex-Date04-15 2026-04-15 (1.73)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.17%
PT rev (3m)2.59%
EPS NQ rev (1m)-14.29%
EPS NQ rev (3m)-17.33%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.15%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.73%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.01 | ||
| Fwd PE | 12.42 | ||
| P/S | 5.9 | ||
| P/FCF | 20.24 | ||
| P/OCF | 18.95 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.46 |
EPS(TTM)10.19
EY5%
EPS(NY)16.41
Fwd EY8.05%
FCF(TTM)10.07
FCFY4.94%
OCF(TTM)10.76
OCFY5.28%
SpS34.58
BVpS-1.85
TBVpS-51.76
PEG (NY)0.41
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.26 |
F-Score8
WACC8.98%
ROIC/WACC1.61
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.78%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%7.72%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y14.94%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%12.43%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.37%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y12.35%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / ABBV Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
What is the valuation status for ABBV stock?
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.
What is the profitability of ABBV stock?
ABBVIE INC (ABBV) has a profitability rating of 7 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 20.01 and the Price/Book (PB) ratio is -110.29.
Is the dividend of ABBVIE INC sustainable?
The dividend rating of ABBVIE INC (ABBV) is 7 / 10 and the dividend payout ratio is 278.48%.